IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
21 Agosto 2024 - 10:15PM
Business Wire
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet
healthcare innovation, today announced that Jay Mazelsky, President
and Chief Executive Officer, and Brian McKeon, Executive Vice
President and Chief Financial Officer, will participate in a
fireside chat at the Morgan Stanley 22nd Annual Global Healthcare
Conference on Wednesday, September 4, 2024 from 11:30 am – 12:05 pm
(EDT).
A live audio webcast of the presentation will be available
through a link on the IDEXX website, www.idexx.com/investors. An
archived edition of the presentation will be available via the same
link.
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our
diagnostic and software products and services create clarity in the
complex, constantly evolving world of veterinary medicine. We
support longer, fuller lives for pets by delivering insights and
solutions that help the veterinary community around the world make
confident decisions—to advance medical care, improve efficiency,
and build thriving practices. Our innovations also help ensure the
safety of milk and water across the world and maintain the health
and well-being of people and livestock. IDEXX Laboratories, Inc. is
a member of the S&P 500® Index. Headquartered in Maine, IDEXX
employs approximately 11,000 people and offers solutions and
products to customers in more than 175 countries and territories.
For more information about IDEXX, visit www.idexx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240821703657/en/
Investor Relations investorrelations@idexx.com
Grafico Azioni IDEXX Laboratories (NASDAQ:IDXX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni IDEXX Laboratories (NASDAQ:IDXX)
Storico
Da Nov 2023 a Nov 2024